State Ledger
Company profile

Oric Pharmaceuticals, Inc. CIK 1796280

Ticker
ORIC (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
South San Francisco, CA 94080
Fiscal year end
2025 (FY)
Market Data
Close
$12.01
Change
-$0.02
Change %
-0.12%
Volume
48,464

ORIC · trading date Oct 9, 2026 · previous close $12.02 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$129.47M
Total assets
$408.89M
Total liabilities
$24.53M
Stockholders' equity
$384.36M
Cash & equivalents
$45.67M
Operating income
-$143.00M
Operating cash flow
-$110.97M
Capital expenditures
$712.0K

Fiscal year 2025, via 10-K filed 2026-02-23. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$111.68M
Free cash flow margin
—
Liabilities / assets
6.0%
Equity / assets
94.0%
CapEx / revenue
—
Operating cash flow / net income
0.86×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$129.47M $408.89M $24.53M $384.36M
2024 — -$127.85M $274.14M $31.02M $243.12M
2023 — -$100.70M $252.01M $27.92M $224.09M
2022 — -$89.12M $247.18M $24.83M $222.35M
2021 — -$78.72M $298.64M $25.67M $272.98M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-08-28
Financials filed via
Form 10-K
filed 2026-02-23

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
South San Francisco, CA 94080
240 E. GRAND AVE.
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies